Clicky

VIVA Biotech Holdings(1873)

Description: Viva Biotech Holdings, an investment holding company, provides structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide. The company provides discovery biology services, include protein expression and purification, structural biology, hit discovery, bioassay, biomolecular interaction, and pharmacokinetics; chemistry services, such as medicinal and synthetic chemistry, analytical chemistry, purification preparation, and computer-aided drug design services, as well as offers chemical technology platforms; and antibody drug research and development services, include antigen preparation, multi-species discovery, monoclonal antibodies, antibodies functional screening and identification, antibody engineering transformation, antibody characteristics, and antibody cell line engineering transformation, as well as offers technology platforms, such as hybridoma, phage and yeast display, mammalian display, VHH antibody technology, high throughput sequencing, computer-aided drug design, HDX-MS, crystal structure determination of protein, and SPR technology. It also provides cell lines, crystal structures, GPCR proteins, antibodies, and proteins. In addition, the company offers contract development and manufacturing services for small molecule active pharmaceutical ingredients (APIs) and intermediates; and trades in APIs, intermediates, and formulations, as well as equity for service. Further, it provides research service; laboratory rental services; and project management and bidding services, as well as sells compounds. The company was incorporated in 2008 and is headquartered in Shanghai, China.


Keywords: Biotechnology Biology Project Management Immunology Antibodies Drug Discovery Active Pharmaceutical Ingredients Antibody Monoclonal Antibody Manufacturing Services Glycoproteins Pharmacokinetics Drug Design Antibody Solutions Antibody Technology Chemistry Services Computer Aided Drug Design Services John Mccafferty Pharmaceutical Customers Single Domain Antibody Structure Based Drug Discovery Services

Home Page: www.vivabiotech.com.cn

No.735, Ziping Road
Shanghai, 201318
China
Phone: 86 21 6089 3288


Officers

Name Title
Dr. Chen Cheney Mao Ph.D. Chairman & CEO
Dr. Delin Ren Ph.D. Pres & Exec. Director
Mr. Zheren Wang C.F.A. Chief Financial Officer
Mr. Xueheng Cheng Ph.D. Chief Technology Officer
Dr. Zhixiong Ye Ph.D. Chief Scientific Officer
Mr. Ying Wu M.B.A. Exec. VP & Exec. Director
Mr. Han Dai Ph.D. CIO & Head of Viva BioInnovator
Mr. Jianhua Cai Ph.D. Sr. VP
Jianguo Ma Ph.D. Sr. VP & CEO of Langhua Pharmaceutical
Mr. Xianyong Bu Ph.D. Sr. VP

Exchange: HK

Country: HK

Currency: Hong Kong Dollar (HK$)

Forward PE: 0
Trailing PE: 20.7778
Price-to-Book MRQ: 0.8386
Price-to-Sales TTM: 1.5331
IPO Date:
Fiscal Year End: December
Full Time Employees: 2309
Back to stocks